Back to LCTX
Salomon & Ludwin, LLC LCTX Position History
Lineage Cell Therapeutics, Inc.
Quarters held
4
Latest value
$447K
Q3 2026
Peak value
$571K
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $21K |
| Q1 2026 | $19K |
| Q2 2026 | $571K |
| Q3 2026 | $447K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $447K | 13.1K | — | — |
| Q2 2026 | $571K | 13.1K | — | — |
| Q1 2026 | $19K | 582 | — | — |
| Q4 2025 | $21K | 582 | — | — |
Other funds holding LCTX
$537.7M
$391.7M
$332.9M
$299.1M
$259.1M
$242.5M
$238.9M
$219.8M
Other Salomon & Ludwin, LLC positions
ETHA
$81.9MISHARES S&P 500 GROWTH ETF
STT-PG
$81.7MSTATE STREET TECHNOLOGY SELECT SECTOR SPDR ETF
ETHA
$79.1MISHARES S&P 500 GROWTH
ETHA
$77.3MISHARES SHORT-TERM
ETHA
$77.3MISHARES SHORT-TERM NATIONAL MUNI BOND ETF
ETHA
$76.3MISHARES SHORT-TERM
ETHA
$75.8MISHARES S&P 500 GROWTH
STT-PG
$75.3MSTATE STREET TECHNOLOGY